NCT06605885Completed
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
This study is a multicenter, observational, prospective study to evaluate the asthma biologic use features and clinical outcomes in China. Patients will undergo clinical assessments and receive standard medical care as determined by the treating physician.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 202 (actual)
- First submitted
- 12 Sept 2024
- Start date
- 14 Nov 2024
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- AstraZeneca
- Diseases
- Asthma
- NCT number
- NCT06605885
What you commit to
- Study type: Observational
- Participants enrolled: 202
- From 14 Nov 2024 to the primary completion date, 1 Sept 2026
- 29 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any significant disease or disorder which, in the opinion of the investigator, may either put the patient at risk because of participation in the study with the usage of biologics, or may influence the results of the study, or the patient's ability to participate in the study
Other
- Participation in an interventional study within the last 3 months.
Who the study is looking for
- Chinese, Female or Male
- Age: no limitation
- Physician-confirmed asthma diagnosis with documented evidence of diagnosis or evidence of variable expiratory airflow limitation (e.g., from bronchodilator reversibility testing or other tests).
- Participants or their legal guardians must be able to provide informed consent.
- Prescription of asthma biologics at enrolment.
Sex: All · Accepts healthy volunteers
Sites (29)
Sites in registry order. Pick your city on the disease page to sort them by distance.
This page is information, not medical advice. Discuss any trial with your doctor.